Total revenue for the quarter rose by 34 per cent yoy to Rs. 15,407 crore in Q4FY18 vs Rs. 11,473 crore in Q4FY18. Also, for the full year revenue grew by 31 per cent yoy to Rs. 56,521 crore in FY18 vs Rs .43,157 crore in FY17. 

The small-cap and mid-cap themes which were the darling of the investors for the last couple of years are bleeding like anything now. The theme had served manifold returns to investors till the end of 2017. But the year 2018 dawned with huge challenges for these themes. 

The shares of MM Forgings surged 8 per cent on the bourses, on Wednesday as the company decides to consider bonus issue as well as interim dividend as wells as a fund raising at its AGM, scheduled to be held on May 28, 2018.

Mutual fund industry will change more in the next 5 years than what it changed in the last 20 years. Read on to find the major changes. 

The share price of stainless steel manufacturer Mukand charted up by over 3 per cent in the intraday trade on Wednesday as a Japanese firm Sumitomo Corporation purchased 49 per cent stake in the joint venture of the company for an amount of Rs. 1181 crore. 

Following stocks are close to their 52-week low as of 12.44 p.m. on May 23, 2018

Following stocks are close to their 52-week high as of 12.44 p.m. on May 23, 2018.

During the quarter, the commercial production commenced at greenfield manufacturing facility for industrial Packaging products at Vizag.

India’s pharma major, Sun Pharmaceutical Industries has received the approval of US drug regulator for YONSA, a combination medication to treat metastatic castration-resistant prostate cancer (mCRPC) patients.

These are the stock where short build up position is seen